NCT02716103View on ClinicalTrials.gov

Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

November 21, 2016

Primary Completion Date

September 4, 2020

Study Completion Date

September 4, 2020

Conditions
Amyloidosis
Interventions
OTHER

blood collection

OTHER

bone marrow collection

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
lead

Boston Medical Center

OTHER